Elisha Josev

Elisha K. Josev, MSc, PhD, is a registered psychologist and a postdoctoral researcher at the Murdoch Children’s Research Institute, Melbourne, Victoria, Australia where she coordinates a paediatric chronic fatigue syndrome research program. Her work includes the use of activin B as a serum biomarker of ME/CFS, the development of the weighted standing time (WST) as a simple proxy for ME/CFS symptom severity, and ME/CFS with comorbid POTS.

Research studies

• 2017, Sleep Quality in Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) (Full text)

Talks and interviews

• 13 Mar 2019, Mapping Fatigue in the Brain in Paediatric ME/CFS given at the International Research Symposium, Geelong, Australia, sponsored by Emerge Australia

serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.